Candidiasis Global Clinical Trials Review H1 2017
ReportsWeb.com published “Candidiasis Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, July 27, 2017 ) Publisher's clinical trial report "Candidiasis Global Clinical Trials Review H1 2017" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region country (G7 & E7) phase trial status end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials) . Publisher Clinical Trial Reports are generated using Publisher's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries conferences journals news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
For more information about this report at http://www.reportsweb.com/candidiasis-global-clinical-trials-review-h1-2017
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region Country (G7 & E7) Trial Status Trial Phase Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title Phase and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global regional and country level
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001881610/buying
Table of Content
List of Tables 4
List of Figures 5
Report Guidance 6
Publisher Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries Proportion of Candidiasis to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries Proportion of Candidiasis to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Candidiasis Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Candidiasis 31
May 30 2017 Cidara Therapeutics Announces Presentations at ASM Microbe 2017 and the 22nd Congress of the European Hematology Association 31
May 24 2017 Eight SCY-078 Data Presentations at ASM Microbe 2017 Confirm Potential of SCYNEXIS' Lead Agent to Combat Serious and Life-threatening Fungal Infections 31
May 11 2017 Potent in vitro Activity of SCYNEXIS SCY-078 Against Multidrug-Resistant Fungal Pathogen Candida auris Further Confirmed in an in vitro Study Conducted by the Centers for Disease Control and Prevention 32
May 08 2017 SCYNEXIS Provides Update on IV Formulation Development Status 33
Apr 25 2017 Eight Data Presentations at ECCMID Showcase the Broad Applicability of SCYNEXIS' Lead Anti-infective Candidate SCY-078 33
Apr 17 2017 Cidara Therapeutics to Present Data on Novel Antifungal CD101 at ECCMID and SID Annual Meetings 34
Clinical Trial Profile Snapshots 35
Appendix 212
Abbreviations 212
Definitions 212
Research Methodology 213
Secondary Research 213
About Publisher 214
Contact Us 214
Source 214
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001881610/buying
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
For more information about this report at http://www.reportsweb.com/candidiasis-global-clinical-trials-review-h1-2017
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region Country (G7 & E7) Trial Status Trial Phase Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title Phase and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global regional and country level
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001881610/buying
Table of Content
List of Tables 4
List of Figures 5
Report Guidance 6
Publisher Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries Proportion of Candidiasis to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries Proportion of Candidiasis to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Candidiasis Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Candidiasis 31
May 30 2017 Cidara Therapeutics Announces Presentations at ASM Microbe 2017 and the 22nd Congress of the European Hematology Association 31
May 24 2017 Eight SCY-078 Data Presentations at ASM Microbe 2017 Confirm Potential of SCYNEXIS' Lead Agent to Combat Serious and Life-threatening Fungal Infections 31
May 11 2017 Potent in vitro Activity of SCYNEXIS SCY-078 Against Multidrug-Resistant Fungal Pathogen Candida auris Further Confirmed in an in vitro Study Conducted by the Centers for Disease Control and Prevention 32
May 08 2017 SCYNEXIS Provides Update on IV Formulation Development Status 33
Apr 25 2017 Eight Data Presentations at ECCMID Showcase the Broad Applicability of SCYNEXIS' Lead Anti-infective Candidate SCY-078 33
Apr 17 2017 Cidara Therapeutics to Present Data on Novel Antifungal CD101 at ECCMID and SID Annual Meetings 34
Clinical Trial Profile Snapshots 35
Appendix 212
Abbreviations 212
Definitions 212
Research Methodology 213
Secondary Research 213
About Publisher 214
Contact Us 214
Source 214
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001881610/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results